The updated BDX stock price forecast incorporates strong balance sheet fundamentals with debt-to-equity under 1, making the company well-positioned for expansion and shareholder value growth. The high three-year median payout ratio of 68% (or a retention ratio of 32%) for Becton Dickinson suggests that the company's growth wasn't really hampered despite it returning most of its income to its shareholders. Waters Corporation (NYSE:WAT), is a global leader in analytical instruments, separations technologies, and software, serving the life, materials, food, and environmental sciences for over 65 years. Our Company helps ensure the efficacy of medicines, the safety of food and the purity of water, and the quality and sustainability of products used every day. In over 100 countries, our 7,600+ passionate employees collaborate with customers in laboratories, manufacturing sites, and hospitals to accelerate the benefits of pioneering science. The latest BDX stock price forecast aligns with broader healthcare industry resilience, as investors rotate towards defensive stocks amid economic uncertainty. Earnings per share projections have been revised slightly upward to $12.20 for FY